Cutaneous Basal Cell Carcinoma In Situ: A Review of the World Literature.
Cohen PR, Kurzrock R.
Cureus. 2024 Sep 19;16(9):e69691. doi: 10.7759/cureus.69691. eCollection 2024 Sep.
Cutaneous Basal Cell Carcinoma In Situ: A Case Series.
Cohen PR.
Cureus. 2022 Sep 23;14(9):e29479. doi: 10.7759/cureus.29479. eCollection 2022 Sep.
Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma.
Schütz S, Solé-Boldo L, Lucena-Porcel C, Hoffmann J, Brobeil A, Lonsdorf AS, Rodríguez-Paredes M, Lyko F.
Nat Commun. 2023 Sep 5;14(1):5413. doi: 10.1038/s41467-023-41141-9.
Superficial Basal Cell Carcinoma of the Skin Is a Cutaneous Basal Cell Carcinoma In Situ.
Cohen PR.
Skinmed. 2024 Aug 2;22(3):165-167. eCollection 2024.
Cutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine.
Selm LC, Morr C, Badiavas EV, Nichols A, Ioannides T.
J Drugs Dermatol. 2024 Apr 1;23(4):275-276. doi: 10.36849/JDD.7507.
Clinical ABCDE rule for early melanoma detection.
Duarte AF, Sousa-Pinto B, Azevedo LF, Barros AM, Puig S, Malvehy J, Haneke E, Correia O.
Eur J Dermatol. 2021 Dec 1;31(6):771-778. doi: 10.1684/ejd.2021.4171.
Merkel cell carcinoma in situ: A systematic review of prognosis and management.
Truong K, Goldinger SM, Chou S, Howle JR, Veness MJ, Fernandez-Peñas P, Varey AHR.
Australas J Dermatol. 2022 Feb;63(1):e6-e12. doi: 10.1111/ajd.13758. Epub 2021 Dec 7.
Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study.
Knuutila JS, Kaijala O, Lehto S, Vahlberg T, Nissinen L, Kähäri VM, Riihilä P.
Acta Derm Venereol. 2024 Nov 27;104:adv40990. doi: 10.2340/actadv.v104.40990.
Safety and Efficacy of TGF-beta1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ.
Nestor M, Berman B, Lu P, Molyneaux M.
J Drugs Dermatol. 2022 May 1;21(5):472-477. doi: 10.36849/JDD.6384.
Combination topical 5-fluorouracil 5%/calcipotriene 0.005% cream for the treatment of cutaneous in situ squamous cell carcinoma: A pilot study.
Patel RT, Fagan KK, Quan EY, Johnson NM, Tegge AN, Holliday AC, Grider DJ, Rush PS, Prickett KA, Eikenberg JD, Phillips MA.
J Am Acad Dermatol. 2024 Dec;91(6):1277-1278. doi: 10.1016/j.jaad.2024.08.039. Epub 2024 Aug 24.
